Reply to McCarthy et al.: Lipid-Laden Macrophages Are Not Diagnostic of Pulmonary Alveolar Proteinosis Syndrome and Can Indicate Lung Injury
Open Access
- 15 October 2020
- journal article
- letter
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 202 (8), 1198-1199
- https://doi.org/10.1164/rccm.202005-2072le
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- A Unique Case of Secondary Pulmonary Alveolar Proteinosis after E-Cigarette, or Vaping, Product Use-associated Lung InjuryAmerican Journal of Respiratory and Critical Care Medicine, 2020
- Chemical Constituents Involved in E-Cigarette, or Vaping Product Use-Associated Lung Injury (EVALI)Toxics, 2020
- Lung Biopsy Findings in Severe Pulmonary Illness Associated With E-Cigarette Use (Vaping) A Report of Eight CasesAmerican Journal of Clinical Pathology, 2020
- Pulmonary alveolar proteinosisNature Reviews Disease Primers, 2019
- Bacterial Yield from Quantitative Cultures of Bronchoalveolar Lavage Fluid in Patients with Pneumonia on Antimicrobial TherapyThe Korean Journal of Internal Medicine, 2012
- Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in JapanEuropean Respiratory Journal, 2011
- Pulmonary alveolar proteinosis: diagnosis using routinely processed smears of bronchoalveolar lavage fluid.Journal of Clinical Pathology, 1997
- Bronchoalveolar Lavage Cytology in Pulmonary Alveolar ProteinosisAmerican Journal of Clinical Pathology, 1996
- Diagnosis and management of alveolar proteinosis: the role of electron microscopy.Thorax, 1975